Format

Send to

Choose Destination
Br J Haematol. 2014 Jan;164(2):299-302. doi: 10.1111/bjh.12612. Epub 2013 Oct 18.

Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL.

Author information

1
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Haematology Unit, AOU Policlinico, Modena, Italy.

KEYWORDS:

ALL; BCR-ABL1; Imatinib; MRD; T cells

PMID:
24134676
DOI:
10.1111/bjh.12612
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center